Financial support for off-label prescription in patients with severe adverse drug reaction due to cancer chemotherapy

Financial support for off-label prescription in patients with severe adverse drug reaction due to cancer chemotherapy - How to support financially for off-label prescription

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000003071

Enrollment

150

Registered

2010-01-31

Start date

2010-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer

Interventions

Medical cost payment

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Breast cancer patients Reducing chemotherapy dose may affect clinical efficacy Informed consent

Exclusion criteria

Exclusion criteria: Contraindication for medication

Design outcomes

Primary

Measure	Time frame
Adverse drug reactions	—

Countries

Japan

Contacts

Public ContactTomoko Okuda

kyoto University Hospital Department of Breast Surgery

oku@kuhp.kyoto-u.ac.jp075-751-3660

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026